Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.83%592.87B | 0.56%2.4T | 1.49%582.2B | 3.10%2.39T | 2.74%572.17B | 0.04%619.85B | 6.21%620.83B | 3.59%573.64B | 3.38%2.31T | 1.22%556.9B |
| Cost of revenue | 1.99%549.61B | 0.29%2.21T | 1.10%538.88B | 3.10%2.2T | 2.68%525.55B | -0.17%572.04B | 6.56%570.64B | 3.53%533.01B | 3.06%2.14T | 1.38%511.82B |
| Gross profit | -0.12%43.27B | 3.77%192.23B | 6.59%43.32B | 3.09%185.25B | 3.42%46.62B | 2.54%47.81B | 2.30%50.18B | 4.37%40.64B | 7.39%179.69B | -0.52%45.08B |
| Operating expense | -0.87%37.68B | 3.15%155.11B | 3.91%38.01B | 2.23%150.37B | 3.72%38.27B | 2.06%37.85B | -0.13%37.67B | 3.37%36.58B | -0.09%147.09B | -2.98%36.89B |
| Operating profit | 5.30%5.59B | 6.45%37.13B | 30.82%5.31B | 6.97%34.88B | 2.04%8.36B | 4.42%9.95B | 10.39%12.51B | 14.25%4.06B | 62.08%32.61B | 12.35%8.19B |
| Net non-operating interest income (expenses) | 33.33%32M | 14.63%141M | -27.27%24M | -4.65%123M | -35.56%29M | -20.00%32M | 7.41%29M | 94.12%33M | -11.03%129M | -39.19%45M |
| Non-operating interest income | 27.27%42M | 9.64%182M | -25.00%33M | -2.92%166M | -29.09%39M | -15.69%43M | 8.11%40M | 57.14%44M | -12.76%171M | -35.29%55M |
| Non-operating interest expense | 11.11%10M | -4.65%41M | -18.18%9M | 2.38%43M | 0.00%10M | 0.00%11M | 10.00%11M | 0.00%11M | -17.65%42M | -9.09%10M |
| Net investment income | -7.45%447M | -5.13%1.39B | -8.87%483M | 4.36%1.46B | 2.10%243M | 0.21%485M | 1.50%203M | 10.88%530M | -10.88%1.4B | 19.60%238M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -12.35%497M | 105.91%10.93B | 11,440.00%567M | 66,475.00%5.31B | -2,829.09%-1.5B | 4,116.00%2.11B | 13,177.78%4.71B | 93.51%-5M | -100.11%-8M | -35.29%55M |
| Income from associates and other participating interests | -123.65%-439M | -156.38%-636M | 972.83%1.86B | -4.00%1.13B | 163.31%445M | -25.47%278M | -31.56%232M | -41.16%173M | 69.31%1.18B | 12.67%169M |
| Special income (charges) | -78.95%4M | 160.25%523M | -81.90%19M | 84.96%-868M | 62.89%-2.07B | 927.91%1.07B | 133.33%24M | 1,600.00%105M | 30.14%-5.77B | -28.14%-5.57B |
| Less:Other special charges | 78.95%-4M | -76.29%-1.77B | 81.90%-19M | -121.12%-1B | -95.75%193M | -927.91%-1.07B | -133.33%-24M | -1,600.00%-105M | -25.90%4.75B | 82.20%4.55B |
| Less:Write off | ---- | -33.39%1.25B | ---- | 83.71%1.87B | ---- | ---- | ---- | ---- | -44.86%1.02B | ---- |
| Other non-operating income (expenses) | 118.51%157M | 6.68%814M | -546.32%-848M | -28.36%763M | -46.85%236M | -33.10%95M | -7.28%242M | -12.84%190M | 19.66%1.07B | 38.75%444M |
| Income before tax | -15.15%6.29B | 17.51%50.29B | 45.81%7.41B | 39.87%42.79B | 60.62%5.74B | 33.61%14.02B | 48.93%17.95B | 13.57%5.08B | 36.07%30.59B | -5.25%3.58B |
| Income tax | 2.25%2.5B | 14.43%15.78B | 40.17%2.45B | 34.24%13.79B | 59.61%2.23B | 38.32%4.41B | 38.98%5.41B | -2.95%1.75B | 28.25%10.28B | -46.98%1.39B |
| Net income | -23.73%3.78B | 18.98%34.5B | 48.73%4.96B | 42.72%29B | 61.18%3.52B | 31.57%9.61B | 53.67%12.54B | 24.72%3.34B | 40.40%20.32B | 90.57%2.18B |
| Net income continuous operations | -23.73%3.78B | 18.98%34.5B | 48.76%4.96B | 42.72%29B | 61.26%3.52B | 31.56%9.61B | 53.68%12.54B | 24.67%3.34B | 40.40%20.32B | 90.65%2.18B |
| Noncontrolling interests | 200.00%1M | 137.50%6M | 85.71%-1M | 38.46%-16M | 0.00%-3M | 57.14%-3M | 70.00%-3M | -16.67%-7M | -133.33%-26M | 25.00%-3M |
| Net income attributable to the company | -23.78%3.78B | 18.89%34.5B | 48.47%4.96B | 42.62%29.02B | 61.13%3.52B | 31.49%9.61B | 53.53%12.54B | 24.65%3.34B | 41.35%20.35B | 90.08%2.18B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -23.78%3.78B | 18.89%34.5B | 48.47%4.96B | 42.62%29.02B | 61.13%3.52B | 31.49%9.61B | 53.53%12.54B | 24.65%3.34B | 41.35%20.35B | 90.08%2.18B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -17.65%52.63 | 27.02%454.58 | 58.19%63.91 | 51.34%357.88 | 69.87%47.58 | 39.04%118.32 | 63.22%151.58 | 32.50%40.4 | 44.90%236.47 | 112.68%28.01 |
| Diluted earnings per share | -17.65%52.63 | 27.02%454.58 | 58.19%63.91 | 51.34%357.88 | 71.69%45.3241 | 39.04%118.32 | 63.22%151.58 | 32.50%40.4 | 44.90%236.47 | 102.05%26.3985 |
| Dividend per share | 0 | 25.00%100 | 0 | 11.11%80 | 11.11%40 | 0 | 11.11%40 | 0 | 0.00%72 | 0.00%36 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |